ARCHIVES

FDA Expands Nexavar Indication To Include Thyroid Cancer

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

In Brief: Fisher, Moore, Metcalf to Share Hammer Prize; NCAB Hearing On Organ Systems Program Dec. 3

October 30, 1987

New Understanding of drug Resistance Exciting Revolution

September 17, 1982

First Panel Meeting On Centers Generates Possible Recommendations For Core Grant Guideline Changes

April 6, 1984

Linda Weiss, director of NCI Office of Cancer Centers, to Retire in March 2015

November 26, 2014

Clinical Trials: NCI Removes Brooklyn Site From PLCO Trials

October 24, 1997

NCI Taps Harlow To Head Office of Science Policy

July 26, 1996